Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010

Journal of Hepatology

Volumn 63, Issue 4, 2015, Pages 822-828

  Allison, Robert D ^a   Tong, Xin ^a   Moorman, Anne C ^a   Ly, Kathleen N ^a   Rupp, Loralee ^b   Xu, Fujie ^a   Gordon, Stuart C ^b   Holmberg, Scott D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Cancer; Hepatitis C virus; Incidence; Mortality; SEER

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BRONCHUS CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER OF UNKNOWN PRIMARY SITE; CANCER REGISTRY; CAUSE OF DEATH; CHRONIC HEPATITIS C; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PHARYNX CANCER; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH CANCER; THYROID CANCER; UNITED STATES; AGE; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; HEPATITIS C, CHRONIC; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASMS; SURVIVAL RATE; TRENDS;

ADULT; AGE FACTORS; AGED; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84941940324     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.04.021     Document Type: Article

References (42)

1. M.M. Denniston, R.B. Jiles, J. Drobeniuc, and et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 Ann Intern Med 160 2014 293 300
2. C.W. Shepard, L. Finelli, and M.J. Alter Global epidemiology of hepatitis C virus infection Lancet Infect Dis 5 2005 558 567
3. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
4. S.F. Altekruse, K.A. McGlynn, and M.E. Reichman Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 2009 1485 1491
5. J.F. Perz, G.L. Armstrong, L.A. Farrington, Y.J. Hutin, and B.P. Bell The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 2006 529 538
6. H.B. El-Serag, H. Hampel, C. Yeh, and L. Rabeneck Extrahepatic manifestations of hepatitis C among United States male veterans Hepatology 36 2002 439 445
7. T.P. Giordano, L. Henderson, O. Landgren, and et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus JAMA 297 2007 2010 2017
8. S.C. Gordon, D. Moonka, K.A. Brown, and et al. Risk for renal cell carcinoma in chronic hepatitis C infection Cancer Epidemiol Biomarkers Prev 19 2010 1066 1073
9. J. Nobles, C. Wold, M. Fazekas-May, J. Gilbert, and P.L. Friedlander Prevalence and epidemiology of hepatitis C virus in patients with squamous cell carcinoma of the head and neck Laryngoscope 114 2004 2119 2122
10. E. Zuckerman, T. Zuckerman, A.M. Levine, and et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma Ann Intern Med 127 1997 423 428
11. S. Sanjose, Y. Benavente, C.M. Vajdic, and et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium Clin Gastroenterol Hepatol 6 2008 451 458
12. A.S. Duberg, M. Nordström, A. Törner, and et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection Hepatology 41 2005 652 659
13. M. Montella, L. Pezzullo, A. Crispo, and et al. Risk of thyroid cancer and high prevalence of hepatitis C virus Oncol Rep 10 2003 133 136
14. Y. Nagao, M. Sata, K. Tanikawa, K. Itoh, and T. Kameyama High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer J Oral Pathol Med 24 1995 354 360
15. A. Nieters, B. Kallinowski, P. Brennan, and et al. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH Gastroenterology 31 2006 1879 1886
16. L.H. Omland, D.K. Farkas, P. Jepsen, N. Obel, and L. Pedersen Hepatitis C virus infection and risk of cancer: a population-based cohort study Clin Epidemiol 2 2010 179 186
17. S. Sanjose, A. Nieters, J.J. Goedert, and et al. Role of hepatitis C virus infection in malignant lymphoma in Spain Int J Cancer 111 2004 81 85
18. J.J. Spinelli, A.S. Lai, M. Krajden, and et al. Hepatitis C virus and the risk of non-Hodgkin lymphoma in British Columbia, Canada Int J Cancer 122 2008 630 633
19. F.H. Su, S.N. Chang, P.C. Chen, F.C. Sung, C.T. Su, and C.C. Yeh Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study BMC Cancer 11 2011 495
20. F.H. Su, S.N. Chang, P.C. Chen, and et al. Positive association between hepatitis C infection and oral cavity cancer: a nationwide population-based cohort study in Taiwan PLoS One 7 2012 e48109
21. A. Swart, L. Burns, L. Mao, A.E. Grulich, and et al. The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study BMJ Open Access 2 2012 e001755
22. S.M. Woo, J. Joo, W.J. Lee, and et al. Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study J Korean Med Sci 28 2013 247 251
23. M.H. Lee, H.I. Yang, S.N. Lu, and et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study J Infect Dis 206 2012 469 477
24. A.C. Moorman, S.C. Gordon, L.B. Rupp, and et al. Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study Clin Infect Dis 56 2013 40 50
25. National Cancer Institute. Surveillance, epidemiology, and end results. Information for cancer registrars, http://seer.cancer.gov/about/overview.html, 2015 [Accessed on March 31].
26. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, editors, et al. SEER cancer statistics review, 1975-2011, National Cancer Institute: Bethesda, MD, 2015 at < http://seer.cancer.gov/csr/1975-2011/ >, [Accessed on March 31].
27. National Cancer Institute. Surveillance, epidemiology, and end results, http://www.seer.cancer.gov, 2015 [Accessed on March 31].
28. K.N. Ly, J. Xing, R.M. Klevens, R.B. Jiles, J.W. Ward, and S.D. Holmberg The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007 Ann Intern Med 156 2012 271 278
29. National Center for Health Statistics U.S. Standard Death Certificate 2003 Centers for Disease Control and Prevention Hyattsville, MD [Accessed on March 31, 2015, at < http://www.cdc.gov/nchs/data/dvs/death11-03final-acc.pdf >]
30. P. Patel, D.L. Hanson, P.S. Sullivan, and et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003 Ann Intern Med 148 2008 728 736
31. L. Arcaini, and R. Bruno Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas Curr Clin Pharmacol 5 2010 74 81
32. O. Hermine, F. Lefrère, J.P. Bronowicki, X. Mariette, K. Jondeau, V. Eclache-Saudreau, and et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection N Engl J Med 347 2002 89 94
33. J. Boscarino, M. Lu, A. Moorman, S. Gordon, L. Rupp, P. Spradling, and et al. Holmberg S for the Chronic Hepatitis Cohort Study (CHeCS) Hepatology 2014 10.1002/hep.27422 [E-pub ahead of print]
34. C.A. Schoenborn, P.F. Adams, and J.A. Peregoy Health behaviors of adults: United States, 2008-2010 Vital Health Stat 10 2013 1 173
35. N. Kamar, J. Izopet, L. Alric, C. Guilbeaud-Frugier, and L. Rostaing Hepatitis C virus-related kidney disease: an overview Clin Nephrol 69 2008 149 160
36. D. Sansonno, G. Lauletta, M. Montrone, G. Grandaliano, F.P. Schena, and F. Dammacco Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection Clin Exp Immunol 140 2005 498 506
37. S.C. Gumber, and S. Chopra Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations Ann Intern Med 123 1995 615 620
38. S. Silverman Jr. Oral lichen planus: a potentially premalignant lesion J Oral Maxillofac Surg 58 2000 1286 1288
39. Y. Nagao, M. Sata, S. Noguchi, T. Seno'o, M. Kinoshita, T. Kameyama, and et al. Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues J Oral Pathol Med 29 2000 259 266
40. American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA). Recommendations for Testing, Managing, and Treating Hepatitis C, at www.hcvguidelines.org, 2015 [Accessed on March 31].
41. European Association for the Study of the Liver EASL recommendations on treatment of hepatitis C 2014 J Hepatol 61 2014 373 395
42. S.D. Holmberg, P.R. Spradling, A.C. Moorman, and M.M. Denniston Hepatitis C in the United States N Engl J Med 368 2013 1859 1861